Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Chelating Agents Market: Comprehensive Research Study, Trends, Share, And Forecast 2028By: axiom market research & consulting CHELATING AGENTS MARKET REPORT OUTLOOK The global chelating agent market is anticipated to grow significantly during the forecast period. The key factor driving the growth of market is increase in demand for potable water as there is rapid population growth in developing countries, particularly in urban areas are creating great demand for chelating agent. Also rise in the use of environmentally friendly chelating agents in agriculture, food and beverages, personal care products, pharmaceuticals, pulp and paper, textiles, water treatment, and oil field applications is further fueling the growth for chelating agents market. Besides increasing awareness about homecare products is propelling the demand for chelating agents market. CHELATING AGENTS MARKET KEY PLAYER The key players in chelating agents market are Akzonobel N.V., Archer Daniels Midland Company (ADM), BASF SE, Cargill, Incorporated, The Dow Chemical Company, Merck KGaA, Lanxess AG, Kemira OYJ, Tate & Lyle PLC, Emd Millipore, Mitsubishi Rayon Co., Ltd, Nouryon, Nippon Shokubai Co., Ltd., Osam Speciality Chemicals Pvt. Ltd., Adm, Hexion, Ava Chemicals Private Limited, Nuova DOT srl and Zhonglan Industry Co.,Ltd. among others. CHELATING AGENTS MARKET RECENT DEVELOPMENT November 2020: BASF had introduced Neutrol MGDA, a readily biodegradable complexing agent for personal care applications. It is readily biodegradable and stands out due to its excellent ecological and toxicological profile. Complexing agents are used in cosmetic products to form very stable complexes with metal ions, thereby inactivating their negative influences on the final formulation. August 2020: Dr Reddy's laboratories had launched penicillamine capsules in us. It is a chelating agent used in the treatment of Wilson's disease and to reduce cystine excretion in cystinuria and to treat patients with severe, active rheumatoid arthritis To know the scope of our report get a sample on https://www.axiommrc.com/ End
|
|